Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | MME | P08473 | 1/20 | 0.31 |
| ▸ | ACE | P12821 | 1/20 | 0.31 |
| ▸ | CPA1 | P15085 | 1/20 | 0.31 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.31 |
| ▸ | MMP1 | P03956 | 1/20 | 0.30 |
| ▸ | MMP2 | P08253 | 1/20 | 0.30 |
| ▸ | MMP3 | P08254 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL960219 | 0.78 | ALDH1A1 (0.40) | CYP2C9MMEACECPA1ACE2 | |
| SCHEMBL31036601 | 0.78 | CYP2D6 (0.37) | CYP2C9MMEACECPA1ACE2 | |
| SCHEMBL11782126 | 0.78 | ALDH1A1 (0.40) | CYP2C9MMEACECPA1ACE2 | |
| SCHEMBL5744109 | 0.78 | CYP2C9 (0.48) | CYP2C9MMEACECPA1ACE2 | |
| SCHEMBL12824659 | 0.78 | ALDH1A1 (0.40) | CYP2C9MMEACECPA1ACE2 | |
| SCHEMBL13545130 | 0.76 | CAD (0.36) | CYP2C9MMEACECPA1ACE2 | |
| SCHEMBL22372624 | 0.76 | MME (0.38) | CYP2C9MMEACECPA1ACE2 | |
| SCHEMBL8915661 | 0.74 | ACACB (0.35) | CYP2C9MMP1MMP2MMP3 | |
| SCHEMBL14816710 | 0.74 | ACACB (0.35) | CYP2C9MMP1MMP2MMP3 | |
| SCHEMBL8917694 | 0.74 | ACACB (0.35) | CYP2C9MMP1MMP2MMP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200354404-A1 | PEPTIDOMIMETIC AGENTS, SYNTHESIS AND USES THEREOF | THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH (US) | 2020-11-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200354404-A1 | PEPTIDOMIMETIC AGENTS, SYNTHESIS AND USES THEREOF | DNPEP, PEPD, ANPEP | CYP2C9 4664/4885MME 32/4885ACE 101/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.